Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease

NCT01137955 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: Rifaximin
DRUG: Placebo

Sponsor

Columbia University

Collaborators

[object Object]